OTC · Financial Statements
Kaleido Biosciences, Inc. (KLDO) Financial Statements
$0.00
OTC: KLDO
Market Cap $426
Overview Financials Dividend Kaleido Biosciences, Inc. most recently reported annual revenue of $1.0M, net profit of $-90.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2017 2018 2019 2020 2021 Revenue $0 $0 $0 $1.0M $1.0M Operating Profit $-27.0M $-61.0M $-87.0M $-79.0M $-88.0M Net Profit $-28.0M $-62.0M $-85.0M $-82.0M $-90.0M EPS $-1.23 $-2.10 $-3.31 $-2.44 $-2.16 Op Margin — — — -8089.6% -7940.9%
Balance Sheet (USD)
Metric 2017 2018 2019 2020 2021 Total Assets $31.0M $85.0M $82.0M $59.0M $50.0M Total Liabilities $74.0M $27.0M $33.0M $39.0M $40.0M Cash $28.0M $76.0M $71.0M $46.0M $38.0M Borrowings $15.0M $15.0M $20.0M $21.0M $22.0M
Cash Flow (USD)
Metric 2017 2018 2019 2020 2021 Operating Cash Flow $-22.0M $-46.0M $-76.0M $-62.0M $-77.0M Investing Cash Flow $-3.0M $-6.0M $-7.0M $-8.0M $-2.0M Financing Cash Flow $3.0M $-2.0M $-1.0M $3.0M $0 Net Cash Flow $26.0M $50.0M $-5.0M $-25.0M $-8.0M Free Cash Flow $-24.0M $-49.0M $-79.0M $-66.0M $-78.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.20 FCF Yield -18362206.57% Quick Ratio 1.43 Interest Coverage -30.89 Return 1Y -90.00% Return 3Y -90.00% Return 5Y -100.00%
Screens featuring this stock